Nurse Practitioner, Family · Bell Gardens, CA
NPI
1932506201
Since 2014
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
6501 Garfield Ave
Bell Gardens, CA, 90201
Phone (562) 928-9600
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$504K
1,085 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Helen Van prescribed most often to Medicare patients was Ozempic (Semaglutide), with 144 prescriptions and refills. In total Helen Van wrote 1,085 Medicare prescriptions that cost $504K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-18.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Ozempic Semaglutide | 144 | 156 | 49 | $110K |
| Humulin N Insulin Nph Human Isophane | 114 | 342 | 65 | $27K |
| Humulin N Kwikpen Insulin Nph Human Isophane | 113 | 327 | 72 | $37K |
| Humulin R Insulin Regular, Human | 108 | 317 | 69 | $21K |
| Humulin 70/30 Kwikpen Insulin Nph Hum/Reg Insulin Hm | 79 | 237 | 45 | $27K |
| Insulin Glargine-Yfgn Generic | 71 | 213 | 50 | $11K |
| Glipizide Generic | 71 | 235 | 42 | $909 |
| Humalog Kwikpen U-100 Insulin Lispro | 55 | 170 | 37 | $23K |
| Humulin R U-500 Kwikpen Insulin Regular, Human | 49 | 149 | 35 | $150K |
| Metformin Hcl Er Metformin Hcl | 30 | 95 | 19 | $307 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 29 | 76 | 18 | $1,022 |
| Victoza 2-Pak Liraglutide | 26 | 31 | 14 | $20K |
| Jardiance Empagliflozin | 25 | 72 | Under 11 | $11K |
| Humulin 70-30 Insulin Nph Hum/Reg Insulin Hm | 24 | 75 | 14 | $6,781 |
| Metformin Hcl Generic | 24 | 77 | 15 | $308 |
Brand drugs: 881 claims; generic drugs: 144 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Helen Van were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.